Liquid Biopsy Guides First-of-Its-Kind Immunotherapy Win in Relapsed Lymphoma
A high tumor mutational burden detected by liquid biopsy guided nivolumab treatment that produced a durable complete remission in a ...
Tag: circulating tumor DNA
Blood Test Reading Tumor Methylation Patterns Outperforms CEA in Real-World Colorectal Cancer Detection
A five-gene plasma cfDNA methylation assay detected colorectal cancer with substantially higher sensitivity than CEA in a real-world cohort of ...
Blood Test Steers Chemotherapy Decisions in Colon Cancer Trial
The phase 2 PEGASUS trial tested whether serial circulating tumor DNA measurements can safely guide de-escalation or escalation of adjuvant ...
Trust and Information Habits Drive Public Enthusiasm for Blood Tests That Screen Many Cancers at Once
A national study of 6,728 U.S. adults finds that trust in physicians, science, and the healthcare system, along with cancer ...
Liquid Biopsy Offers a Non-Invasive Path to Precision Treatment for Bladder Cancer
A new review in the Journal of Translational Medicine synthesizes a decade of evidence showing that liquid biopsy analytes such ...
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
A large multi-institution study found that metastatic breast cancer patients in high deprivation neighborhoods had more TP53 mutations, lower use ...
Bispecific Antibody Meets Antibody-Drug Conjugate in Promising Small Cell Lung Cancer Trial
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
Pancreatic Cancer’s Moving Target: New Framework Calls for Continuously Evolving Treatment
A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...
Hidden ESR1 Mutations Signal Trouble Before Breast Cancer Progresses
A large U.S. real-world study found that ESR1 mutations emerging during first-line therapy for ER-positive metastatic breast cancer are linked ...
ESR1 Testing Stays Rare in Metastatic Breast Cancer Even as Mutations Emerge
A real-world study of over 8,500 US patients with ER-positive/HER2-negative metastatic breast cancer found that ESR1 mutation testing remains rare ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!